BIOMERICA INC
BMRA$13M
Micro CapNASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaIRVINE
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
This month
Market Overview
Stock performance and key metrics
BMRA News
Catalyst Timeline
1 upcoming, 1 past
EarningsNext
BMRA Earnings Report
October 2026~Estimated
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Aug/2026 | Call: tbd
Drug Pipeline
No drugs found in this phase.
📑
→Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
Catalyst Verdict
Full breakdown — the signals behind the verdict
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is BIOMERICA INC's next FDA catalyst?→
BIOMERICA INC's (BMRA) next tracked catalyst is a Earnings expected October 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BMRA biotech catalysts?→
Add BMRA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow BIOMERICA INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply